Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.6 was added, replacing the previous v3.6.5, indicating a minor backend/template update.
    Difference
    0.0%
    Check dated 2026-09-01T19:47:38.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The NIH grant/contract year 2017 was added to the study identifiers. This supplements the existing EudraCT number with funding context for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:44:04.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a software update or patch applied to the page.
    Difference
    0.0%
    Check dated 2026-08-11T14:42:02.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a new release version. This appears to be a minor internal update with no user-facing content changes on the study page.
    Difference
    0.0%
    Check dated 2026-07-28T05:41:36.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added, replacing v3.6.2, indicating a platform update. This change does not affect the study details or other content on the page.
    Difference
    0.0%
    Check dated 2026-07-06T16:43:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.0 to v3.6.2, indicating a newer build of the page. No study content or data appears to be affected.
    Difference
    0.0%
    Check dated 2026-06-29T08:57:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.